Veralto R&D remained flat by 0.0% to $68.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $64.00M to $68.00M. Over 3 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 2.9% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $61.00M | $61.00M | $61.00M | $52.00M | $53.00M | $56.00M | $57.00M | $55.00M | $57.00M | $60.00M | $61.00M | $63.00M | $69.00M | $64.00M | $67.00M | $67.00M | $68.00M | $68.00M |
| QoQ Change | — | +0.0% | +0.0% | -14.8% | +1.9% | +5.7% | +1.8% | -3.5% | +3.6% | +5.3% | +1.7% | +3.3% | +9.5% | -7.2% | +4.7% | +0.0% | +1.5% | +0.0% |
| YoY Change | — | — | — | -14.8% | -13.1% | — | — | +5.8% | +7.5% | +7.1% | +7.0% | +14.5% | +21.1% | +6.7% | +9.8% | +6.3% | -1.4% | +6.3% |
Range$52.00M – $69.00M
CAGR+2.6%
Avg YoY Growth+4.8%
Median YoY Growth+6.7%
Current Streak4 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is Veralto's r&d?
- Veralto (VLTO) reported r&d of $68.00M in Q1 2026.
- How has Veralto's r&d changed year-over-year?
- Veralto's r&d increased by 6.3% year-over-year, from $64.00M to $68.00M.
- What is the long-term trend for Veralto's r&d?
- Over 3 years (2021 to 2025), Veralto's r&d has grown at a 2.9% compound annual growth rate (CAGR), from $244.00M to $266.00M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.